14 On a mission to support its clientele throughout their clinical development journey, Anatomise Biostats is a specialised consulting firm that offers a comprehensive range of services in biostatistics, data science, statistical programming, bioinformatics, and complex adaptive systems modelling. The company focuses on enhancing clinical trial insights, an endeavour that has led Anatomise Biostats to be named in the Healthcare and Pharmaceuticals Awards 2024. Join us below as we speak with Sarah Seppelt Baker, Managing Director of Anatomise Biostats, to learn more. Headquartered in London, Anatomise Biostats strives to aid medical device and pharmaceutical start-ups and small to medium-sized enterprises in their R&D and clinical trials projects throughout the regulatory approval process and beyond. Ultimately, the company hopes to facilitate innovation across the life sciences sector whilst assuring patient benefit and safety, offering a comprehensive service that provides support throughout the entire journey. Anatomise Biostats’s places a specific focus on leveraging advanced statistical methodologies and data-driven approaches to enhance every aspect of the clinical trial process. Using data science and statistical programming, Anatomise Biostats ensures that complex datasets are efficiently managed and analysed in order to yield meaningful results. What’s more, the company’s bioinformatics services aid in interpreting biological data, which is a crucial component of understanding disease mechanisms and the effects of treatments. Additionally, Anatomise Biostats’s expertise in complex adaptive systems modelling allows the company to simulate and analyse intricate biological and clinical systems, providing detailed insights into potential outcomes and interactions within trials. The integration of such diverse, yet interconnected services enables Anatomise Biostats to help its clients uncover deeper insights from their clinical data, make informed decisions, and accelerate their path to market. The company understands that start-ups and SMEs face unique challenges, such as limited resources and tight timelines, and in response, offers customised solutions that not only meet regulatory standards but also drive innovation. “At Anatomise Biostats, our core values are integrity, excellence, collaboration, and efficiency,” says Sarah. “We are committed to providing top tier biostatistical consulting services that uphold the highest ethical standards. Our goal is to empower medical device and pharmaceutical start-ups and SMEs by delivering robust statistical analyses that accelerate their clinical trial processes.” Driven by its core values, Anatomise Biostats allows these qualities to guide it through its operations. Integrity enables the company to conduct its work with honesty and transparency, ensuring that its analyses are reliable and trustworthy. Anatomise Biostats’s reverence for excellence motivates it to maintain the highest quality in its services, working to continually improve its methodologies and remain ahead of industry advancements. Of all its values, collaboration is key to Anatomise Biostats’s approach; the company firmly believes that collaborating closely with clients directly leads to better understanding of their requirements and makes for more effective solutions. Efficiency is equally important to its operations, as clinical trials often suffer from waste and redundancy in their work processes, which results in delays and increased costs. Through streamlining workflows and integrating innovative analytical tools, Anatomise Biostats aims to eliminate such inefficiencies. Taking this approach enables the company to save time and resources for its clientele, as well as contributing to more environmentally conscious practices within the industry. “By integrating these values into every aspect of our work, we build strong and lasting relationships with our clients,” Sarah explains. “Our commitment to integrity, excellence, collaboration, and efficiency not only enhances our success, but also contributes more positively to the industry by promoting more effective and ethical clinical research practices.” The life sciences sector is a rapidly evolving field, with continuous technological advancements, research methodologies, and changes in global regulations continually reshaping the landscape. In order to succeed and thrive in such a high-pressure climate, companies must deliver something that is as unique as it is crucial to the industry. Anatomise Biostats’s uniqueness lies within its comprehensive and integrated approach to biostatistical consulting. The company combines advanced biostatistics with data science, statistical programming, bioinformatics, and complex adaptive systems modelling to provide in-depth analytical solutions tailored to the specific and varying needs of medical device and pharmaceutical start-ups and SMEs. One of the company’s key differentiators is its specialised expertise in bioinformatics for biomarker discovery, leveraging advanced bioinformatics techniques to identify and validate biomarkers. This capability is crucial in the development of diagnostic assays, such as liquid biopsies, and allows Anatomise Biostats to support its clients in advancing innovative diagnostic tools that can detect diseases with more accuracy and speed. Furthermore, Anatomise Biostats recognises that the industry is increasingly shifting towards personalised medicine as a direction for product development. The company helps clients to identify patient populations more likely to respond to a treatment based on Best Bioinformatic & Biostatistical Consultancy Firm 2024 – UK
RkJQdWJsaXNoZXIy NTY1MjM3